Using MRI-guided planning to improve proton radiation for rare bone tumors
Part of Cancer clinical trials.
This trial is testing a better way to plan proton radiation using MRI images, aiming to deliver treatment more accurately for chordoma or chondrosarcoma in the spine/sacrum area. You may benefit if the trial’s planning method helps target the tumor while sparing nearby healthy tissue.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a confirmed diagnosis of chordoma or chondrosarcoma in the spine, sacrum, or clivus.
- Your doctors have accepted you for standard proton beam radiation therapy.
- You can (and will) do MRI scans, including coping with claustrophobia if needed.
- You do not have MRI-incompatible implants (for example, certain metal devices).
- The tumor/lesion is at least 1 centimeter in size.
- You are age 50 or older, and your tumor grade is below WHO 3.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a radiation plan using protons given in either 5 or 25 sessions for chordoma or chondrosarcoma at the skull base. The goal is to shrink or control the tumor while protecting nearby critical nerves and brain structures.
This trial compares two standard treatment approaches—surgery versus definitive radiation—for people with a primary sacral chordoma (a bone tumor at the lower spine/pelvis area). It aims to find which approach works best for controlling the tumor while considering treatment side effects.
This trial is testing whether using only one proton beam per day is as safe and effective as using two beams for treating certain bone and spine tumors. It may help reduce treatment time and side effects.
This study tests a new MRI-based technique to better see the size and shape of bone sarcomas before surgery. The goal is to help surgeons remove all the cancer while saving as much healthy bone as possible.
This trial tests a special type of proton radiation for people whose spine cancer has spread from another part of the body and cannot be treated effectively with standard X-ray radiation. The goal is to see if proton radiation can safely deliver a high dose of radiation to the tumor.
This trial tests whether analyzing blood and tumor samples before and after radiation and surgery can help find personalized markers for chordoma. It is for patients with chordoma of the skull base, spine, or sacrum who will receive radiation before surgery.
Hear when a new Chordoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.